Home · Guides · Ozempic vs Mounjaro: Which Changes Your Diet More?

Ozempic vs Mounjaro: Which Changes Your Diet More?

Ozempic is a single-target drug (GLP-1). Mounjaro is a dual-target drug (GLP-1 plus GIP), and that second target is the whole story: it delivers more weight loss, and it delivers it faster. In the SURMOUNT-1 trial, tirzepatide hit 22.5% average weight loss at the top dose — around half again what semaglutide achieves.

Side by side

	A	B
Targets	GLP-1 only	GLP-1 + GIP (dual)
Peak dose	2.0 mg weekly	15 mg weekly
Average weight loss	~7-15%	Up to 22.5% (SURMOUNT-1)
Appetite suppression	Strong	Stronger
Nausea reported	~20-44%	~25-30% across doses

The diet difference

More weight loss means more of it can come from muscle if protein falls short — the 1.2-1.6 g/kg/day target is not optional on Mounjaro.
Faster appetite loss makes 'small frequent meals' more than advice: large portions are more likely to sit heavy and come back up.
Fiber matters on both, but the faster weight loss on Mounjaro makes the fiber-plus-water pairing more important for constipation control.

How the foods score

The same judgment framework runs across this site — protein, fiber and how heavy a food sits on a slow stomach.

Easy on both	Risky on both
Salmon, Sockeye — GLP-1 friendly Quinoa — GLP-1 friendly Lentils — GLP-1 friendly	Donut — Limit White Rice — Limit Rice Cakes — Limit

Common questions

Which drug has stricter food rules?

Mounjaro. Both use the same framework, but the stronger appetite suppression means every rule matters more: protein target, small portions, low-fat choices when nausea is an issue.

Is chicken breast fine on Mounjaro?

Yes — lean protein is the safest category on either drug. It protects muscle and rarely triggers nausea. The caution list is the same: fried foods, heavy sauces, large portions.

Why does Mounjaro cause more weight loss?

The added GIP action amplifies the appetite signal. Clinically that translates to roughly 5-7 percentage points more weight loss, and a correspondingly stronger need to keep protein up.

This comparison presents published trial data (STEP, SURMOUNT, SCALE, OASIS 4) and FDA label information for reference. It is not medical advice and does not recommend any medication. Prescription decisions belong to you and your healthcare provider.

From the blog

Beyond weight loss: GLP-1 drugs may reduce addictive cravings How to say no at a party without explaining your medication On Ozempic, dessert deserves a closer look

All posts